TABLE 3.
RADIOLOGIC AND PATHOLOGIC DATA
| .Imaging Guidelines | Total N=81 | Pathologic Class | ||||
|---|---|---|---|---|---|---|
| <50% | 51–99% | 100% | P value* | |||
| EASL | CR | 31 (38) | 0 | 5 (16) | 26 (84) | <.001 |
| PR | 31 (38) | 4 (13) | 13 (42) | 14 (45) | ||
| SD | 12 (16) | 9 (75) | 3 (25) | 0 | ||
| PD | 7 (9) | 5 (72) | 1 (14) | 1 (14) | ||
| WHO | CR | 1 (1) | 0 | 0 | 1 (100) | 0.015 |
| PR | 31 (38) | 2 (6) | 8 (26) | 21 (68) | ||
| SD | 35 (44) | 9 (26) | 10 (29) | 16 (45) | ||
| PD | 14 (17) | 7 (50) | 4 (29) | 3 (21) | ||
| RECIST | CR | 1 (1) | 0 | 0 | 1 (100) | 0.057 |
| PR | 31 (38) | 2 (6) | 9 (29) | 20 (65) | ||
| SD | 38 (47) | 11 (29) | 11 (29) | 16 (42) | ||
| PD | 11 (14) | 5 (45) | 2 (18) | 4 (37) | ||
| EASLxWHO | 0 | 31 (38) | 0 | 5 (16) | 26 (84) | <.001 |
| 1 | 19 (23) | 2 (10) | 6 (32) | 11 (58) | ||
| 2 | 8 (10) | 1 (12.5) | 5 (62.5) | 2 (25) | ||
| 3 | 4 (5) | 1 (25) | 2 (50) | 1 (25) | ||
| 4 | 11 (14) | 8 (73) | 3 (27) | 0 | ||
| 6 | 1 (1) | 1 (100) | 0 | 0 | ||
| 9 | 7 (9) | 5 (72) | 1 (14) | 1 (14) | ||
EASL=European Association for Study of the Liver, WHO=World Health Organization, RECIST=Response Evaluation Criteria for Solid Tumors, CR=Complete response, PR=Partial response, SD=Stable disease, PD=Progressive disease
*
P value calculated using the Fisher’s Exact Test.